Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1α and PPARβ/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Objective To examine whether rosiglitazone alters gene expression of some key genes involved in mitochondrial biogenesis and oxidative capacity in skeletal muscle of type 2 diabetic patients, and whether this is associated with alterations in skeletal muscle oxidative capacity and lipid content.Design measured in muscle biopsies obtained from diabetic patients, before and after 8 weeks of rosiglitazone treatment, and matched controls. Furthermore, whole-body insulin sensitivity and substrate utilization were assessed.Subjects Ten obese type 2 diabetic patients and 10 obese normoglycemic controls matched for age and BMI.Methods Gene expression and mitochondrial protein content of complexes I-V of the respiratory chain were measured by quantitative polymerase chain reaction and Western blotting, respectively. Histochemical staining was used to quantify lipid accumulation and complex II succinate dehydrogenase (SDH) activity. Insulin sensitivity and substrate utilization were measured during a hyperinsulinemic-euglycemic clamp with indirect calorimetry.Results Skeletal-muscle mRNA of PGC-1 alpha and PPAR beta/delta--but not of other genes involved in glucose, fat and oxidative metabolism--was significantly lower in diabetic patients (P<0.01). Rosiglitazone significantly increased PGC-1 alpha ( approximately 2.2-fold, P<0.01) and PPAR beta/delta ( approximately 2.6-fold, P<0.01), in parallel with an increase in insulin sensitivity, SDH activity and metabolic flexibility (P<0.01). Surprisingly, none of the measured mitochondrial proteins was reduced in type 2 diabetic patients, nor affected by rosiglitazone treatment. No alterations were seen in muscular fat accumulation upon treatment.Conclusion These results suggest that the insulin-sensitizing effect of rosiglitazone may involve an effect on muscular oxidative capacity, via PGC-1 alpha and PPAR beta/delta, independent of mitochondrial protein content and/or changes in intramyocellular lipid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions
Higuchi, R., Fockler, C., Dollinger, G., & Watson, R. (1993) · Nature Biotechnology · doi:10.1038/nbt0993-1026 · Cited by 2,159
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Diet, muscle glycogen and physical performance.
Bergström, J., Hermansen, L., Hultman, E., & Saltin, B. (1967) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1967.tb03720.x · Cited by 1,740
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Table of nonprotein respiratory quotient: an update.
Péronnet, F., & Massicotte, D. (1991) · PubMed · Cited by 1,209
Goodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194
Cited by
Items 101–180 of 180
Maniam, J., Antoniadis, C. P., Wang, K. W., & Morris, M. J. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00138 · Cited by 24
Verma, M. K., Yateesh, A. N., Neelima, K., Pawar, N., Sandhya, K., Poornima, J., Lakshmi, M. N., Yogeshwari, S., Pallavi, P. M., Oommen, A. M., et al. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-255 · Cited by 24
“…in muscle fat storage is contributed by raised plasma FFA level, increased fat uptake (Bonen et al. 2004), and defective or incomplete oxidation in skeletal muscle of diabetic patients (Mootha et al. 2003; Patti et al. 2003; Mensink et al. 2007; Mogensen et al. 2007; Koves et al. 2008).”
BackgroundNabben, M., Hoeks, J., Moonen‐Kornips, E., van Beurden, D., Briedé, J. J., Hesselink, M. K. C., Glatz, J. F. C., & Schrauwen, P. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.11.012 · Cited by 23
“Western blotting was performed using 13% polyacrylamide SDS-gels as described before [2,16].”
MethodSelf-citationTime‐dependent effect of phytocannabinoid treatments in fat cells
Ramlugon, S., Levendal, R. ‐., & Frost, C. L. (2018) · Phytotherapy Research · doi:10.1002/ptr.6047 · Cited by 23
“Previous studies have shown that TZDs can improve mitochondrial function, with Rosi upregulating genes responsible for mitochondrial biogenesis, resulting in significantly increased SDH activity and increased oxidation in muscle fat (Mensink et al., 2007).”
BackgroundImprovement of Insulin Resistance by Chlorella in Fructose‐rich Chow‐fed Rats
Chiu, Y., Chung, H., Yeh, C., Cheng, J., & Lo, S. (2011) · Phytotherapy Research · doi:10.1002/ptr.3379 · Cited by 23
“The hyperinsulinemic‐euglycemic glucose clamp is one of the widely employed methods but this technique is experimentally demanding and costly (Mensink et al., 2007; Su et al., 2009).”
MethodNakamura, S., Miyachi, Y., Shinjo, A., Yokomizo, H., Takahashi, M., Nakatani, K., Izumi, Y., Otsuka, H., Sato, N., Sakamoto, R., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13350 · Cited by 22
Advanced nutritional and stem cells approaches to prevent equine metabolic syndrome
Marycz, K., Michalak, I., & Kornicka, K. (2018) · Research in Veterinary Science · doi:10.1016/j.rvsc.2018.01.015 · Cited by 22
Mitochondrial Dysfunction in Obesity and Diabetes
Sivitz, W. I. (2010) · US Endocrinology · doi:10.17925/use.2010.06.1.20 · Cited by 22
Kugler, B. A., Lourie, J., BERGER, N. J. A., Lin, N., Nguyen, P., DosSantos, E., Ali, A. S., Sesay, A., Rosen, H. G., KALEMBA, B. L., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101802 · Cited by 21
den Bosch, J. D. V., Hoeks, J., Timmers, S., Houten, S. M., van Dijk, P., Boon, W., van Beurden, D., Schaart, G., Kersten, S., Voshol, P. J., et al. (2010) · Obesity · doi:10.1038/oby.2010.152 · Cited by 22
Self-citationMoore‐Carrasco, R., Bustamante, M. P., Guerra, O. G., Leiva, E., Escudero, V., Arellano, C. A., & Palomo, I. F. (2008) · Molecular Medicine Reports · doi:10.3892/mmr.1.3.317 · Cited by 20
Kim, J.-C. (2016) · Physical Activity and Nutrition · doi:10.20463/jenb.2016.06.20.2.6 · Cited by 19
The role of maternal DNA methylation in pregnancies complicated by gestational diabetes
Dias, S. C., Willmer, T., Adam, S., & Pheiffer, C. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.982665 · Cited by 19
Ma, Y., Maruta, H., Sun, B., Wang, C., Isono, C., & Yamashita, H. (2021) · Amino Acids · doi:10.1007/s00726-020-02934-0 · Cited by 17
Németh, Z., Kiss, É., & Takács, I. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709253 · Cited by 17
Sharma, R., Matharoo, K., Kapoor, R., & Bhanwer, A. J. S. (2017) · Molecular Genetics and Genomics · doi:10.1007/s00438-017-1385-2 · Cited by 17
The impact of high altitude (hypobaric hypoxia) on insulin resistance in humans
Adeva‐Andany, M. M., Adeva-Contreras, L., Carneiro-Freire, N., Ameneiros-Rodríguez, E., Vila-Altesor, M., & Calvo‐Castro, I. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01069-8 · Cited by 16
Han, M., You, L., Wu, Y., Gu, N., Wang, Y., Feng, X., Xiang, L.-L., Chen, Y., Zeng, Y., & Zhong, T. (2019) · Bioscience Reports · doi:10.1042/bsr20192523 · Cited by 16
Zhao, Z., Luo, Z., Wang, P., Sun, J. F., Yu, H., Cao, T., Ni, Y., Chen, J., Yan, Z., Liu, D., et al. (2011) · PPAR Research · doi:10.1155/2011/291656 · Cited by 16
“In rosiglitazone-treated obese patients with type 2 diabetes, improved insulin sensitivity and skeletal muscle oxidative enzyme activity is associated with an upregulation of PPARδ expression [35].”
BackgroundCarrara, V. D. S., Amato, A. A., Neves, F. D. A. R., Bazotte, R. B., Mandarino, J. M. G., Nakamura, C. V., Filho, B. P. D., & Cortez, D. A. G. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009000600011 · Cited by 16
McCombie, G., Medina‐Gómez, G., Lelliott, C. J., Vidal‐Puig, A., & Griffin, J. L. (2012) · Metabolites · doi:10.3390/metabo2020366 · Cited by 15
“increasing the expression of both co-activators and stimulating β-oxidation of fatty acids in the skeletal muscle of obese individuals [17].”
BackgroundLai, N., Fealy, C. E., Kummitha, C., Cabras, S., Kirwan, J. P., & Hoppel, C. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00677 · Cited by 15
van den Berg, S. A. A., Nabben, M., Bijland, S., Voshol, P. J., van Klinken, J. B., Havekes, L. M., Romijn, J. A., Hoeks, J., Hesselink, M. K. C., Schrauwen, P., et al. (2010) · Metabolism · doi:10.1016/j.metabol.2010.03.008 · Cited by 15
“A mixture of monoclonal antibodies specific for oxidative phosphorylation (Mitosciences, Eugene, OR) was used to measure mitochondrial density as described before [24].”
MethodSelf-citationLivelo, C., Guo, Y., Madhanagopal, J., Morrow, C. D., & Melkani, G. C. (2024) · Aging Cell · doi:10.1111/acel.14382 · Cited by 13
“…behind preserving muscle physiology is essential to developing therapeutic programs that seek to restore muscle physiology and attenuate the pathophysiological impacts of prevalent metabolic challenges (Guo et al., 2021; Livelo et al., 2023; Mensink et al., 2007; Villanueva et al., 2019 ).”
Choudhury, C., Gill, M. K., McAleese, C. E., Butcher, N. J., Ngo, S. T., Steyn, F. J., & Minchin, R. F. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000835 · Cited by 13
Balampanis, K., Chasapi, A., Kourea, E. P., Tanoglidi, A., Hatziagelaki, E. E., Lambadiari, V., Dimitriadis, G., Lambrou, G. Ι., Kalfarentzos, F., Melachrinou, M., et al. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.08.002 · Cited by 13
Ishizaka, N., Hongo, M., Matsuzaki, G., Furuta, K., Saito, K., Sakurai, R., Sakamoto, A., Koike, K., & Nagai, R. (2010) · Hypertension Research · doi:10.1038/hr.2009.224 · Cited by 13
The roles ofPPARsin human diseases
Li, J., & Liu, Y. (2018) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2018.1475673 · Cited by 13
Bragt, M. C. E., Plat, J., Mensink, M., Schrauwen, P., & Mensink, R. P. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-8 · Cited by 11
Self-citationBakhtiyari, S., Zaherara, M., Haghani, K., Khatami, M., & Rashidinejad, A. (2019) · Lipids · doi:10.1002/lipd.12133 · Cited by 11
Mitochondrial Markers in Aging and Primary Open-Angle Glaucoma
Liu, H., Mercieca, K., & Prokosch, V. (2020) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001448 · Cited by 10
Are Individuals With Type 2 Diabetes Metabolically Inflexible? A Systematic Review and Meta‐Analysis
Hansen, M., Lange, K. K., Stausholm, M. B., & Dela, F. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70044 · Cited by 10
Verma, M. K., Yateesh, A. N., Smitha, R., Neelima, K., Pallavi, P. M., Reddy, M., Poornima, J., Oommen, A. M., Jagannath, M. R., & Somesh, B. P. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-251 · Cited by 9
“During insulin resistance, insulin mediated glucose oxidation comes down (Mensink et al. 2007) and hence fat becomes primary fuel source albeit overall oxidation is reduced.”
InfluentialSex differences in muscle SIRT1 and SIRT3 and exercise + weight loss effects on muscle sirtuins
Ryan, A. S., & Li, G. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702221142619 · Cited by 9
Cited4 is a sex‐biased mediator of the antidiabetic glitazone response in adipocyte progenitors
Bayindir‐Buchhalter, I., Wolff, G., Lerch, S., Sijmonsma, T., Schuster, M., Gronych, J., Billeter, A. T., Babaei, R., Krunic, D., Ketscher, L., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708613 · Cited by 8
“…expressed at comparable levels in skeletal muscle, which is a target of TZDs responding with improved insulin sensitivity and ª 2018 The Authors EMBO Molecular 10: e8613 | 2018 7 of 18 mitochondrial oxidative potential (Kim et al, 2003; Schrauwen et al, 2006; Mensink et al, 2007; Liu et al, 2009).”
BackgroundMaruhashi, T., Kihara, Y., & Higashi, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-2744-4_15 · Cited by 8
Taşkent, İ., Ece, B., & Aydın, S. (2024) · Tomography · doi:10.3390/tomography10070079 · Cited by 7
Diabetes, myometrium, and mitochondria in pregnant women at term
Gam, C. M. B. F., Mortensen, O. H., Larsen, L. H., Poulsen, S. S., Qvortrup, K., Mathiesen, E. R., Damm, P., & Quistorff, B. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1171-6 · Cited by 7
Kim, K.-I., An, S.-M., Park, H.-G., Lee, K.-M., & Lee, W.-L. (2019) · Exercise Science · doi:10.15857/ksep.2019.28.4.365 · Cited by 6
Mitochondrial function in skeletal muscle in type 2 diabetes.
Rabøl, R. (2011) · PubMed · Cited by 6
Maj, M. C., Sriskandarajah, N., Hung, V. W. S., Browne, I., Shah, B., Weadge, A., Jamieson, N. L., Tropak, M. B., Cameron, J. M., Addis, J., et al. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.10.002 · Cited by 6
The effect of antidiabetic drugs on genes regulating lipid metabolism
TOMKIN, G. H. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32831ac56c · Cited by 6
Effects of antidiabetic agents on lipid metabolism of skeletal muscle: A narrative review
Xu, M., Lv, D., Wei, H., Li, Z., Jin, S., Liu, Q., Zhang, Y., & Liu, Y. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16189 · Cited by 5
UCP4 overexpression improves fatty acid oxidation and insulin sensitivity in L6 myocytes
Gao, C., Ni, Y., Liu, G., Chen, X.-H., Ji, C., Qin, D., Kou, C., Zhu, C., Zhang, C., Xia, Z., et al. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9344-9 · Cited by 4
“Current evidence suggests that whole-body metabolic flexibility was lower in type 2 diabetic individuals compared to obesity-matched nondiabetic individuals and that metabolic inflexibility improved after weight loss or anti-diabetic treatment with thiazolidinediones (Mensink et al. 2007).”
BackgroundPharmacological Activation of Mitochondrial Biogenesis for the Treatment of Various Pathologies
Gibbs, W. S., Scholpa, N. E., Beeson, C., & Schnellmann, R. G. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch39 · Cited by 4
Liu, J., Fan, J., & Zhou, B. (2026) · Physiology International · doi:10.1556/2060.2026.00780 · Cited by 3
Wang, C., Chi, K.-T., & Wei, Y. (2012) · InTech eBooks · doi:10.5772/52320 · Cited by 3
Allostatic hypermetabolic response in PGC1α/β heterozygote mouse despite mitochondrial defects
Rodríguez‐Cuenca, S., Lelliott, C. J., Campbell, M., Gopalacharyulu, P. V., Martinez‐Uña, M., Ingvorsen, C., Dias, A. R., Relat, J., Mora, S., Hyötyläinen, T., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100262rr · Cited by 3
Fatouros, I. G., & Mitrakou, A. (2012) · CRC Press eBooks · doi:10.1201/b12085-16 · Cited by 3
Perturbed Brain Energy Metabolism in Alzheimer’s Disease and Diabetes
Wu, L. (2017) · KU ScholarWorks (University of Kansas) · Cited by 3
Skeletal muscle mitochondrial dysfunction in Type 2 diabetes
Pazderska, A., Wanic, K., & Nolan, J. J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.21 · Cited by 2
Zhang, Y. (2012) · Scholarship@Western (Western University) · Cited by 2
Lee, Y.-J., Jang, Y. N., Han, Y.-M., Kim, H.-M., Jeong, J.-M., Son, M. J., Jin, C., Kim, H. J., & Seo, H. S. (2019) · PPAR Research · doi:10.1155/2019/5317126 · Cited by 2
Vaughan, R. A. (2014) · UNM’s Digital Repository (University of New Mexico) · Cited by 1
Intermittent-sprint exercise: performance and muscle adaptations in health and chronic disease
Serpiello, F. R. (2012) · Victoria University Research Repository (Victoria University) · Cited by 1
Habitual physical activity and food intake regulation : physiological and genetic aspects
den Hoed, M. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20090703mh
van Herpen, N. A. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120426nh
Meex, R. C. R. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110908rm
A molecular basis for the loss of muscle oxidative phenotype: Implications for COPD
Remels, A. H. V. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091211ar
Reid, M. B., Mazzatti, D. J., Smith, M., Oita, R. C., Lim, F.-L., Andrew, J. G., Desplanches, D., Andrianjafiniony, T., Dupré-Aucouturier, S., Letexier, D., et al. (2015)
The biochemical characteristics of muscle make the meat
Updike, M. S. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Le rôle des inositols dans la résistance à l'insuline chez l'humain
Villeneuve, M.-C. (2011) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Changes in Cardiotrophin-1 and Fibroblast Growth Factor-21 with Weight Loss
Bowers, R. L. (2009)
Limón, P. R. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
O’Connell, G. C. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6337
Targeting PPARs in metabolic risk management: A pharmacological and nutritional approach
Bragt, M. C. E. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20111214mb
Simões, A. M. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Setyawati, T., Kusuma, R. J., Muhammad, H. F. L., Oktiyani, N., Sunarti, S., Nur, R., & Hendra, S. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.7415
(2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832402a2
Abdelazem, A. S., Assaf, S. A. F. M., Hussein, A. G., & Mousa, M. M. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.233186
Čebron Lipovec, N. (2016) · Repository of the University of Ljubljana (University of Ljubljana)
Mitochondrial function as a target for therapy in type 2 diabetes
Wessels, B. B. (2015) · TU/e Research Portal
Antunes, B. M. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
SGLT2阻害による糖尿病マウスの持久力向上 : ヒラメ筋における内因性AMPK活性化因子AICARPの役割の可能性
Nakamura, S. (2024) · Kyushu University Institutional Repository (QIR) (Kyushu University)
Contrôle de la masse fonctionnelle des cellules β pancréatiques par les glucocorticoïdes et pgc-1α
Besseiche, A. (2015) · theses.fr (ABES) · doi:10.70675/f16ecd6fza687z4a5fzac34zc26774dc9c3f
Song, W., Dong, Y., Wang, X., Xu, F., Jiang, B., Zhou, Y., & Li, Q. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153768
da Silva‐Araújo, E. R., Manhães‐de‐Castro, R., Júnior, O. H. D. S., Júnior, J. P. D. S., Araújo, M. A. D. S., Gouveia, H. J. C. B., Rodrigues, T. D. O., Silva, J. G., Jiménez‐Chillarón, J. C., Hernández, E. P., et al. (2026) · Nutritional Neuroscience · doi:10.1080/1028415x.2026.2738370
The effect of phytocannabinoid treatment on adipogenesis and lipolysis in 3T3-L1 cells
Ramlugon, S. (2014) · Nelson Mandela University Research Repository
The AMPK–SIRT1–PGC-1α Axis in Cardiovascular–Kidney–Metabolic Syndrome
Tănase, D. M., Anton, I.-B., Valasciuc, E., Tărniceriu, C. C., Morariu, P. C., Oancea, A. F., COSTEA, C. F., Hurjui, L. L., Ciocoiu, M., & Floria, M. (2026) · Life · doi:10.3390/life16111894
Metadata
- Authors
- Mensink, M., Hesselink, M. K. C., Russell, A. P., Schaart, G., Sels, J.-P., & Schrauwen, P.
- Affiliations
- Maastricht University (NL)
- Deakin University (AU)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Mensink, M
- Venue
- International Journal of Obesity
- Published
- 2007-02-20
- Volume
- 31
- Issue
- 8
- Pages
- 1302-1310
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2114190855
- Cited by
- 160
- References
- 26
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 11
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Koninklijke Nederlandse Akademie van Wetenschappen
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- rosiglitazone, type 2 diabetes, skeletal muscle, PGC-1α, PPARδ, mitochondrial biogenesis, oxidative capacity, insulin sensitivity, metabolic flexibility, succinate dehydrogenase, intramyocellular lipid, mitochondrial protein content, gene expression
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Rosiglitazone, Biopsy, Blood Glucose, Diabetes Mellitus, Type 2, Gene Expression Regulation, Heat-Shock Proteins, Humans, Hypoglycemic Agents, Insulin Resistance, Male, Middle Aged, Mitochondria, Muscle, Obesity, Transcription Factors, Case-Control Studies, Muscle, Skeletal, Mitochondrial Proteins, Thiazolidinediones, PPAR-beta, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.